TCM
ACLX

TD Capital Management’s Arcellx ACLX Stock Holding History

TD Capital Management’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$326 – 854
2025
Q4 		$326 Hold
5
– – ﹤0.01% 751
2025
Q3 		$411 Hold
5
– – ﹤0.01% 665
2025
Q2 		$329 Hold
5
– – ﹤0.01% 671
2025
Q1 		$328 Buy
+5
New +$339 ﹤0.01% 621

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

TD Capital Management's ACLX Position: Q1 2026 in Review

TD Capital Management sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 5 shares — an estimated $326 sold.

TD Capital Management first reported a position in ACLX in Q1 2025 and held it in 4 quarters. The position peaked at $411 in Q3 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • TD Capital Management reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • TD Capital Management sold 5 Arcellx shares in Q1 2026, an estimated $326.
  • TD Capital Management first reported a position in Arcellx in Q1 2025 and held it in 4 quarters.
  • TD Capital Management's Arcellx position peaked at $411 in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.